Benitec Biopharma Inc. (BNTC) ownership: Top institutional holder: SUVRETTA CAPITAL MANAGEMENT, LLC ($122.99M). Insider activity: Net Buyer (12 buys, 8 sells). SEC EDGAR first-party data.
| Holder | Shares | Market Value | Reported |
|---|---|---|---|
| SUVRETTA CAPITAL MANAGEMENT, LLC | 11548351.00 | $122.99M | 2026-03-31 |
| JANUS HENDERSON GROUP PLC | 2876380.00 | $30.72M | 2026-03-31 |
| FRANKLIN RESOURCES INC | 2378159.00 | $25.33M | 2026-03-31 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 2120672.00 | $22.59M | 2026-03-31 |
| RA CAPITAL MANAGEMENT, L.P. | 1850000.00 | $19.70M | 2026-03-31 |
| VANGUARD GROUP INC | 1174758.00 | $15.82M | 2025-12-31 |
| Nantahala Capital Management, LLC | 1438371.00 | $15.32M | 2026-03-31 |
| BlackRock, Inc. | 1185741.00 | $12.63M | 2026-03-31 |
| Insider | Transaction | Value | Date |
|---|---|---|---|
| Sell | null | 2026-05-26 | |
| Sell | null | 2026-05-26 | |
| Sell | null | 2026-01-22 | |
| Buy | null | 2025-12-23 | |
| Buy | null | 2025-12-23 | |
| Buy | null | 2025-12-23 | |
| Buy | null | 2025-12-23 | |
| Buy | null | 2025-12-23 |
Back to BNTC overview · BNTC earnings · All congressional trades
Institutional data from SEC Form 13F. Insider data from SEC Form 4. Congressional data from STOCK Act disclosures. Not personalized investment advice.